{"id":22920,"date":"2026-09-16T11:09:23","date_gmt":"2026-09-16T09:09:23","guid":{"rendered":"https:\/\/mic-site.labiux.com\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/"},"modified":"2026-09-16T11:09:23","modified_gmt":"2026-09-16T09:09:23","slug":"viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/","title":{"rendered":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas.<\/p>\n<p>Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i izplat\u012bta v\u012brusu infekcija, un da\u017ei \u0161\u012b v\u012brusa tipi var izrais\u012bt v\u0113zi. Latvijas valsts vakcin\u0101cijas kalend\u0101rs paredz valsts apmaks\u0101tu vakcin\u0101ciju pret CPV meiten\u0113m un z\u0113niem no 12 l\u012bdz 17 gadu vecumam, k\u0101 ar\u012b jaunie\u0161iem l\u012bdz 25 gadu vecumam.<\/p>\n<p>Pirmo reizi Latvij\u0101 detaliz\u0113ti dati par vakcin\u0101ciju pret CPV ir pieejami pa\u0161vald\u012bbu l\u012bmen\u012b, \u013caujot sal\u012bdzin\u0101t vakcin\u0101cijas aptveri da\u017e\u0101d\u0101s Latvijas viet\u0101s un sekot t\u0101s izmai\u0146\u0101m. Dati publiski pieejami jaunaj\u0101 Slim\u012bbu un profilakses centra (SPKC) p\u0101rskat\u0101*, kas sniedz iesp\u0113ju iepaz\u012bties ar vakcin\u0101cijas r\u0101d\u012bt\u0101jiem sav\u0101 pa\u0161vald\u012bb\u0101 un sal\u012bdzin\u0101t tos ar situ\u0101ciju citviet Latvij\u0101.<\/p>\n<p>Jaun\u0101kie dati r\u0101da krasas re\u0123ion\u0101l\u0101s at\u0161\u0137ir\u012bbas. Piem\u0113ram, \u0161ogad (pamatojoties uz 3. septembra datiem) J\u0113kabpils novad\u0101 pirmo vakc\u012bnas pret CPV devu sa\u0146\u0113mu\u0161i 63,9% b\u0113rnu 12 gadu vecum\u0101, savuk\u0101rt Saulkrastu novad\u0101 \u2013 tikai 17,4%. T\u0101d\u0113j\u0101di starp ab\u0101m pa\u0161vald\u012bb\u0101m vakcin\u0101cijas aptveres at\u0161\u0137ir\u012bba p\u0101rsniedz vair\u0101k nek\u0101 46 procentpunktus.<\/p>\n<p>\u0160\u0101das at\u0161\u0137ir\u012bbas liecina, ka vakcin\u0101cijas pret CPV aptveri var ietekm\u0113t ne tikai vec\u0101ku individu\u0101l\u0101 izv\u0113le. B\u016btiska noz\u012bme var b\u016bt ar\u012b tam, cik akt\u012bvi \u0123imenes tiek inform\u0113tas un uzrun\u0101tas, cik \u0113rti vakcin\u0101cija ir pieejama un k\u0101 t\u0101s organiz\u0113\u0161ana notiek konkr\u0113taj\u0101 pa\u0161vald\u012bb\u0101. Augst\u0101 vakcin\u0101cijas aptvere vair\u0101kos novados apliecina, ka ar akt\u012bvu l\u012bdzdal\u012bbu ir iesp\u0113jams sasniegt b\u016btiski lab\u0101kus rezult\u0101tus.<\/p>\n<p>Vienl\u012bdz\u012bga piek\u013cuve profilaksei noz\u012bm\u0113, ka b\u0113rna iesp\u0113j\u0101m sa\u0146emt aizsardz\u012bbu pret nov\u0113r\u0161am\u0101m saslim\u0161an\u0101m nevajadz\u0113tu b\u016bt atkar\u012bg\u0101m no vi\u0146a dz\u012bvesvietas. Detaliz\u0113tu datu pieejam\u012bba pa\u0161vald\u012bbu l\u012bmen\u012b \u013cauj ne tikai identific\u0113t vietas, kur\u0101s nepiecie\u0161ami uzlabojumi, bet ar\u012b m\u0101c\u012bties no pa\u0161vald\u012bb\u0101m, kur\u0101s izdevies sasniegt augstu vakcin\u0101cijas aptveri.<\/p>\n<p>Lai nodro\u0161in\u0101tu b\u0113rnam aizsardz\u012bbu pret v\u0113zi un cit\u0101m CPV infekcijas izrais\u012bt\u0101m slim\u012bb\u0101m, vec\u0101ki aicin\u0101ti sazin\u0101ties ar savu \u0123imenes \u0101rstu.<\/p>\n<p>*SPKC dati par vakcin\u0101ciju pret CPV: https:\/\/www.spkc.gov.lv\/lv\/vakcinacija-pret-cpv<\/p>\n<p>Avots: LETA<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13296,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[216,76],"tags":[1481,340,221],"mic_flag":[63],"class_list":["post-22920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktuali","category-jaunakie-raksti","tag-cilveka-papilomas-viruss","tag-cpv","tag-spkc","mic_flag-aktuali"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-16T09:09:23+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-16T09:09:23+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"position\":2,\"name\":\"Jaun\\u0101kie raksti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#listItem\",\"name\":\"Vien\\u0101 novad\\u0101 pret CPV vakcin\\u0113ti 63% b\\u0113rnu, cit\\u0101 vien 17%: dati atkl\\u0101j b\\u016btisku nevienl\\u012bdz\\u012bbu Latvij\\u0101\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#listItem\",\"position\":3,\"name\":\"Vien\\u0101 novad\\u0101 pret CPV vakcin\\u0113ti 63% b\\u0113rnu, cit\\u0101 vien 17%: dati atkl\\u0101j b\\u016btisku nevienl\\u012bdz\\u012bbu Latvij\\u0101\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/jaunakie-raksti\\\/#listItem\",\"name\":\"Jaun\\u0101kie raksti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#newsarticle\",\"name\":\"Vien\\u0101 novad\\u0101 pret CPV vakcin\\u0113ti 63% b\\u0113rnu, cit\\u0101 vien 17%: dati atkl\\u0101j b\\u016btisku nevienl\\u012bdz\\u012bbu Latvij\\u0101 - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Vien\\u0101 novad\\u0101 pret CPV vakcin\\u0113ti 63% b\\u0113rnu, cit\\u0101 vien 17%: dati atkl\\u0101j b\\u016btisku nevienl\\u012bdz\\u012bbu Latvij\\u0101\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/vakcina_pote_vaccine_covid.jpg\",\"width\":1000,\"height\":667},\"datePublished\":\"2026-09-16T11:09:23+03:00\",\"dateModified\":\"2026-09-16T11:09:23+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#webpage\"},\"articleSection\":\"Aktu\\u0101li, Jaun\\u0101kie raksti, cilv\\u0113ka papilomas v\\u012bruss, CPV, SPKC, Aktu\\u0101li\",\"dateline\":\"Published on September 16, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/\",\"name\":\"Vien\\u0101 novad\\u0101 pret CPV vakcin\\u0113ti 63% b\\u0113rnu, cit\\u0101 vien 17%: dati atkl\\u0101j b\\u016btisku nevienl\\u012bdz\\u012bbu Latvij\\u0101 - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Jaun\\u0101kie dati par vakcin\\u0101ciju pret cilv\\u0113ka papilomas v\\u012brusu (CPV) atkl\\u0101j b\\u016btiskas at\\u0161\\u0137ir\\u012bbas starp Latvijas pa\\u0161vald\\u012bb\\u0101m. Kam\\u0113r atsevi\\u0161\\u0137\\u0101s pa\\u0161vald\\u012bb\\u0101s pirmo vakc\\u012bnas devu sa\\u0146\\u0113mu\\u0161i vair\\u0101k nek\\u0101 63% b\\u0113rnu 12 gadu vecum\\u0101, citviet vakcin\\u0101cijas aptvere nesasniedz pat 18%. \\u0160\\u0101das at\\u0161\\u0137ir\\u012bbas aktualiz\\u0113 jaut\\u0101jumu par vienl\\u012bdz\\u012bg\\u0101m iesp\\u0113j\\u0101m sa\\u0146emt profilaktisko vesel\\u012bbas apr\\u016bpi neatkar\\u012bgi no b\\u0113rna dz\\u012bvesvietas. Cilv\\u0113ka papilomas v\\u012bruss ir pla\\u0161i\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/vakcina_pote_vaccine_covid.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#mainImage\",\"width\":1000,\"height\":667},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\\\/#mainImage\"},\"datePublished\":\"2026-09-16T11:09:23+03:00\",\"dateModified\":\"2026-09-16T11:09:23+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs","description":"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i","canonical_url":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","position":2,"name":"Jaun\u0101kie raksti","item":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#listItem","name":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#listItem","position":3,"name":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/#listItem","name":"Jaun\u0101kie raksti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#newsarticle","name":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs","headline":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg","width":1000,"height":667},"datePublished":"2026-09-16T11:09:23+03:00","dateModified":"2026-09-16T11:09:23+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#webpage"},"articleSection":"Aktu\u0101li, Jaun\u0101kie raksti, cilv\u0113ka papilomas v\u012bruss, CPV, SPKC, Aktu\u0101li","dateline":"Published on September 16, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/","name":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs","description":"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#mainImage","width":1000,"height":667},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/#mainImage"},"datePublished":"2026-09-16T11:09:23+03:00","dateModified":"2026-09-16T11:09:23+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs","og:description":"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i","og:url":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg","og:image:width":1000,"og:image:height":667,"article:published_time":"2026-09-16T09:09:23+00:00","article:modified_time":"2026-09-16T09:09:23+00:00","twitter:card":"summary_large_image","twitter:title":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101 - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Jaun\u0101kie dati par vakcin\u0101ciju pret cilv\u0113ka papilomas v\u012brusu (CPV) atkl\u0101j b\u016btiskas at\u0161\u0137ir\u012bbas starp Latvijas pa\u0161vald\u012bb\u0101m. Kam\u0113r atsevi\u0161\u0137\u0101s pa\u0161vald\u012bb\u0101s pirmo vakc\u012bnas devu sa\u0146\u0113mu\u0161i vair\u0101k nek\u0101 63% b\u0113rnu 12 gadu vecum\u0101, citviet vakcin\u0101cijas aptvere nesasniedz pat 18%. \u0160\u0101das at\u0161\u0137ir\u012bbas aktualiz\u0113 jaut\u0101jumu par vienl\u012bdz\u012bg\u0101m iesp\u0113j\u0101m sa\u0146emt profilaktisko vesel\u012bbas apr\u016bpi neatkar\u012bgi no b\u0113rna dz\u012bvesvietas. Cilv\u0113ka papilomas v\u012bruss ir pla\u0161i","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2021\/12\/vakcina_pote_vaccine_covid.jpg"},"aioseo_meta_data":{"post_id":"22920","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 20:40:04","updated":"2026-10-16 20:40:04"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/\" title=\"Jaun\u0101kie raksti\">Jaun\u0101kie raksti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tVien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Jaun\u0101kie raksti","link":"https:\/\/farmacija-mic.lv\/category\/jaunakie-raksti\/"},{"label":"Vien\u0101 novad\u0101 pret CPV vakcin\u0113ti 63% b\u0113rnu, cit\u0101 vien 17%: dati atkl\u0101j b\u016btisku nevienl\u012bdz\u012bbu Latvij\u0101","link":"https:\/\/farmacija-mic.lv\/en\/viena-novada-pret-cpv-vakcineti-63-bernu-cita-vien-17-dati-atklaj-butisku-nevienlidzibu-latvija\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22920"}],"version-history":[{"count":0,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22920\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/13296"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22920"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}